Product
Supplier
Encyclopedia
Inquiry
Vosoritide CAS 1480724-61-5 buy - large image1
Vosoritide CAS 1480724-61-5 buy - image1

Vosoritide CAS 1480724-61-5

74 Inquiries

Unit Price:

$10-12/G FOB

Get Latest Price
CAS No.:

1480724-61-5

Content:

95%

Port:

china

Packaging:

100mg/bottle

Price valid (until):

2027-12-31

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Dicobalt Octacarbonyl,(E,E)-Farnesol,(4S,5R)-4-Methyl-5-phenyloxazolidin-2-one,Geranyl linalool

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Treatment of Disease: Primarily used to treat children with achondroplasia who are 5 years of age or older and still in their growth period.

    Achondroplasia is the most common form of dwarfism, a genetic skeletal disorder. Patients have a gene mutation that impairs the proliferation of chondrocytes in the bone growth plates, resulting in short stature and a range of potential complications.

    Mechanism of Action: Vosoritide is a C-type natriuretic peptide (CNP) analog. It acts on receptors in the bone growth plates, regulating downstream signaling pathways to promote the proliferation and differentiation of chondrocytes, thereby stimulating linear bone growth.

    Basic Info
    Product Name:

    Vosoritide acetate

    Other Name:

    Vosoritide acetate;vosoritide;unii-7se5582q2p

    CAS No.:

    1480724-61-5

    Molecular Weight:

    0

    Color/Form:

    White to off-white

    Categories:

    Other Chemical Drugs

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Dicobalt Octacarbonyl,(E,E)-Farnesol,(4S,5R)-4-Methyl-5-phenyloxazolidin-2-one,Geranyl linalool

    Location:

    11F ,#20 building, #18 Fuquan Road ,Jiangbei District, CHONGQING 400020, P.R China

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    350

    Total Annual Revenue:

    $10 million-$25 million

    Total Employees:

    11-50

    Year of Establishment:

    2010

  • Inquiry History
    74 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Vosoritide acetate Raw Powder CAS 1480724-61-5 Vosoritide

    60 L Jul 21, 2026
    United States

    Factory Supply Pure 98% Vosoritide Acetate Raw Powder CAS 1480724-61-5

    1 G Jun 15, 2026
    United States

    High Quality Vosoritide 99% white powder 1480724-61-5 -Shaanxi Dideu Medichem Co.Ltd

    100 MG Jun 8, 2026
    Australia

    Vosoritide

    20 MG Jul 18, 2026
    United States

    Vosoritide (CNP-39) – Sequence length: 39 amino acids

    10 MG Aug 15, 2025
    Poland

    Vosoritide Acetate

    1 G Feb 9, 2026
    Germany

    Vosoritide

    500 MG Aug 1, 2026
    United States

    Vosoritide

    1 G Sep 5, 2026
    United States

    Vosoritide

    0.3 G Aug 29, 2026
    Romania

    Vosoritide Acetate

    360 MG Aug 22, 2026
    Mexico

    Vosoritide LIOFILIZED

    220 MG Aug 17, 2026
    United States

    Vosoritide Acetate

    500 MG Jul 16, 2026
    Germany

    Vosoritide

    1000 MG Jul 5, 2026
    United States

    Vostoritide

    1 G Jun 10, 2026
    Canada

    Vosoritide

    70 MG Jun 6, 2026
    United States

    Vosorotide

    1 KG May 23, 2026
    United States

    Vosoritide

    1 G Apr 29, 2026
    Canada

    Vosoritide

    Apr 28, 2026
    Australia

    vosoritide

    1 G Apr 9, 2026
    United States

    Vosoritide

    0.500 G Mar 22, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.